NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 87 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $632,000 | -18.3% | 200,000 | 0.0% | 0.38% | -13.3% |
| Q2 2023 | $774,000 | +39.7% | 200,000 | 0.0% | 0.44% | +59.7% |
| Q1 2023 | $554,000 | +153788.9% | 200,000 | 0.0% | 0.27% | +46.0% |
| Q4 2022 | $360 | -99.9% | 200,000 | 0.0% | 0.19% | -15.4% |
| Q3 2022 | $424,000 | -21.2% | 200,000 | 0.0% | 0.22% | -16.3% |
| Q2 2022 | $538,000 | -38.0% | 200,000 | 0.0% | 0.26% | -18.5% |
| Q1 2022 | $868,000 | -16.2% | 200,000 | 0.0% | 0.32% | -15.4% |
| Q4 2021 | $1,036,000 | -15.6% | 200,000 | 0.0% | 0.38% | -10.3% |
| Q3 2021 | $1,228,000 | -39.2% | 200,000 | 0.0% | 0.43% | -17.2% |
| Q2 2021 | $2,020,000 | – | 200,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 16,298,006 | $43,842,000 | 30.79% |
| Madrona Venture Group, LLC | 6,020,770 | $16,196,000 | 7.52% |
| AH Equity Partners LSV II, L.L.C. | 1,355,911 | $3,647,000 | 3.82% |
| Ally Bridge Group (NY) LLC | 1,080,566 | $2,907,000 | 2.65% |
| Tikvah Management LLC | 1,488,895 | $4,005,000 | 1.73% |
| ArchPoint Investors | 1,449,551 | $3,899,000 | 1.54% |
| Perceptive Advisors | 9,111,151 | $24,508,000 | 0.77% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $5,380,000 | 0.63% |
| CROWN ADVISORS MANAGEMENT, INC. | 250,000 | $672,000 | 0.62% |
| Affinity Asset Advisors, LLC | 466,607 | $1,255,000 | 0.53% |